sales@contrivedatuminsights.com
CDI - Contrive Datum Insights
Press ReleaseChemicals & Materials

Disposable Gloves Market Forecast to USD 29.6 billion by 2034, Growing 7.49% a Year

North America leads with 32% of 2025 revenue, while Others grows fastest at 9.11% across the forecast period.

PUNE, INDIA — 21 SEPTEMBER 2026CONTRIVE DATUM INSIGHTS

From USD 15.6 billion in 2025 to USD 29.6 billion in 2034, a 7.49% compound annual rate.

32% of 2025 revenue (USD 4.99 billion) is generated in North America.

Fastest growth: Others at 9.11% a year.

58% of 2025 revenue sits in Nitrile Gloves, the largest material line.

Contrive Datum Insights has published "Disposable Gloves Market Size, Share & Industry Analysis, By Material (Natural Rubber Latex Gloves, Nitrile Gloves, Polyvinyl Chloride (PVC) Gloves, Others), Application (Healthcare & Medical, Industrial, Food Industry, Others), Form (Powder-Free, Powdered), Distribution channel (Direct/Institutional Sales, Retail Pharmacies & Medical Stores, Online Retail), Sterility (Non-sterile, Sterile), and Regional Forecast, 2026-2034". The study sizes the global disposable gloves market at USD 15.6 billion in 2025 and projects growth from USD 16.6 billion in 2026 to USD 29.6 billion by 2034, a compound annual growth rate of 7.49% across the forecast period.

Disposable gloves are single-use hand protection made primarily from nitrile, natural rubber latex or polyvinyl chloride, manufactured through a dipping process and sold in boxes for one-time use before disposal. They serve two broad buyer groups: healthcare providers, including hospitals, clinics and diagnostic laboratories, who use them for examination and infection control, and industrial and food-service buyers who use them for contamination control, chemical handling and general workplace safety. Buyers choose between materials and grades based on allergy risk, chemical resistance, tactile sensitivity and cost, since no single specification serves every use case.

Expansion of healthcare infrastructure and infection-control protocols

Expansion of healthcare infrastructure and infection-control protocols is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 7.49% a year, the material lines exposed to it move fastest: Others compounds at 9.11%, taking its share of revenue from 7% to 8% and its value from USD 1.09 billion to USD 2.37 billion.

The study also runs a bull case: the bull case assumes nitrile capacity expansion proceeds without a repeat of the 2022-2023 oversupply and price correction, and that healthcare infrastructure spending in Asia Pacific and Latin America accelerates faster than currently budgeted. That path ends 2034 at USD 33.15 billion, above the USD 29.6 billion base case.

Against that, the bear case assumes nitrile butadiene rubber prices spike again as they did in 2021, compressing margins and realized dollar values even if unit volumes continue to grow, and that regulatory-driven healthcare procurement growth in emerging markets slows. On that reading 2034 revenue stops at USD 26.64 billion. The weight of the problem sits in Natural Rubber Latex Gloves: 20% of 2025 revenue growing at 4.05%, well under the market's 7.49%.

The Competitive Split Runs by Material

Two positions matter, and they are set by material. Nitrile Gloves carries 58% of 2025 revenue (USD 9.05 billion) and is still the largest line in 2034 at 63%, hard to take from an incumbent. Others, at 9.11%, is where the USD 15.6 billion base is redistributed. The two demand different capabilities.

Other Findings in the Study

SegmentLed 2025 byShare & valueFastest-growing
MaterialNitrile Gloves58% · USD 9.05 billion
ApplicationHealthcare & Medical57% · USD 8.89 billion
FormPowder-Free88% · USD 13.73 billion
Distribution channelDirect/Institutional Sales62% · USD 9.67 billionOnline Retail 13.89%
SterilityNon-sterile84% · USD 13.1 billionSterile 8.3%
  • Regionally, the lead sits with North America: 32% of 2025 global revenue, USD 4.99 billion rising to USD 8.58 billion in 2034.
  • Asia Pacific takes a rising share of global revenue over the forecast period, from 28% in 2025 to 33% in 2034, with revenue growing from USD 4.37 billion to USD 9.77 billion.
  • Middle East and Africa stays the smallest contributor across the period: 7% of revenue in 2025 and 7% in 2034.
  • The fastest material line is Others, forecast to compound at 9.11% through the period.
  • The United States is the largest single country market at USD 4.24 billion in 2025, 27.18% of global revenue.

Coverage runs to five axes, by material, and by application, form, distribution channel and sterility, with a revenue figure and a growth rate for every line in every year from 2020 to 2034, and bear, base and bull cases on the headline total at USD 26.64 billion and USD 33.15 billion by 2034. All five regions are broken out to country level, alongside the competitive landscape and the methodology behind each estimate. The study is delivered as a PDF, and a free sample can be requested.

Regions Covered
North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa
About Contrive Datum Insights

Contrive Datum Insights is a global market intelligence and consulting firm working across investment, information technology, healthcare and manufacturing markets. Every market we publish is sized twice — once top-down from the leading players and once bottom-up from the addressable base — and validated by primary interview. More about CDI.

Asia Pacific
Kunjir Shyama Prestine, Sr. no. 174/1
Jagtap Diary Road, Pimple Saudagar
Pune 411017, India
+91 983 481 6757
United States
21C2 Lakeshore Dr.
Farmington, CT 06032
United States
+1 215 297 4078